Grant: Team Grant: DSEN Collaborating Centre - Network Meta-Analysis
Ottawa Hospital Research Institute
$916,427.00
Network meta-analysis: an important tool for drug safety and effectiveness
EF 2011-12
Résumé
Systematic reviews and meta-analyses typically aggregate knowledge about the effects and safety of interventions, such as drugs. They are now used by clinicians, policy analysts and others to help make practice decisions as well and policy/management decisions. A recent estimate suggests that 11 systematic reviews are published daily. As enthusiastic as these developments are there is still much to learn about specific types of meta-analyses, such as multiple treatment comparisons (MTC). Such comparisons may better help understand drug safety and effectiveness. This proposal aims to address several questions about MTC using innovative statistical procedures with freely available software. The answers to these questions will help clinicians and policy makers better understand the usefulness of MTC as part of assessing the safety and effectiveness of drugs. This is important for all Canadians.
Programme
Team Grant: DSEN Collaborating Centre - Network Meta-Analysis
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
237862
Name
Moher David
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Team Grant: Network Meta-Analysis and Innovative RCT Designs
Projecttitle
Network meta-analysis: an important tool for drug safety and effectiveness
Programtype2
Operating Grants
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$916,427
Cihrequipment2
$10,500
Programname2
Team Grant: DSEN Collaborating Centre - Network Meta-Analysis
Keyworddelim
Capacity Building; Indirect Comparisons; Innovative Systematic Reviews; Knowledge Synthesis; Knowledge Translation; Network Meta-Analyses; Networking
Abstract
Systematic reviews and meta-analyses typically aggregate knowledge about the effects and safety of interventions, such as drugs. They are now used by clinicians, policy analysts and others to help make practice decisions as well and policy/management decisions. A recent estimate suggests that 11 systematic reviews are published daily. As enthusiastic as these developments are there is still much to learn about specific types of meta-analyses, such as multiple treatment comparisons (MTC). Such comparisons may better help understand drug safety and effectiveness. This proposal aims to address several questions about MTC using innovative statistical procedures with freely available software. The answers to these questions will help clinicians and policy makers better understand the usefulness of MTC as part of assessing the safety and effectiveness of drugs. This is important for all Canadians.
Competitiondate
201106
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Moher, David; Mills, Edward J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $916,427~ $10,500~
